Biological implications and clinical value of mir-210 in gastrointestinal cancer
Wanli Yang(National Clinical Research Center for Digestive Diseases), Liu Hong(National Clinical Research Center for Digestive Diseases), Bo Cao(National Clinical Research Center for Digestive Diseases), Wei Zhou(Broad Institute), Jiaojiao Ma(Sun Yat-sen University), Daiming Fan(National Clinical Research Center for Digestive Diseases), Xin Zhou(Qingdao University)
Cited by 11
Related Papers
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
|The Lancet Oncology|2015|1.6k
lncRNA MIR100HG-derived miR-100 and miR-125b mediate cetuximab resistance via Wnt/β-catenin signaling
|Nature Medicine|2017|460
Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells
|Proceedings of the National Academy of Sciences|2011|256
Challenges in the management of acute peptic ulcer bleeding
|The Lancet|2013|234
Tunicamycin specifically aggravates ER stress and overcomes chemoresistance in multidrug-resistant gastric cancer cells by inhibiting N-glycosylation
|Journal of Experimental & Clinical Cancer Research|2018|230